Healthcare / Biotechnology
Regeneron Pharmaceuticals, Inc.REGN
Regeneron discovers, makes and sells medicines, mostly antibodies, and earns in three ways.
- Edition
- Nov 6, 2026
- Covers
- Q3 2026
- Length
- 7 pages
In This Report
- 1SummaryThe takeaway, the case for and what could go wrong
- 2Financial HealthSales, margins, cash flow and debt over the years
- 3Business TrendsThe segments and the operating numbers the company reports
- 4Dividend ProfileThe dividend's record, its growth, and how well cash and earnings cover it
- 5ValuationThe price against the stock's own history and the intrinsic value models
- 6Outlook and RisksAnalyst estimates, guidance and the risks to watch
- 7MethodologyGlossary, sources and disclosures